Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease — Stella

Home/Charcot-Marie-Tooth Disease Type 1A/

View on ClinicalTrials.gov

Recruiting

Back to Charcot-Marie-Tooth Disease Type 1A trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

Assistance Publique - Hôpitaux de Marseille, Marseille

Key details

Sponsor

Assistance Publique Hopitaux De Marseille

Collaborators

Association Française contre les Myopathies (AFM), Paris, University Medical Center Göttingen

Enrollment target

~55 participants

Started

June 2025

Primary completion

June 2027

Age range

10 Years – 30 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.